KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Depreciation and Depletion (2017 - 2025)

Guardant Health (GH) has disclosed Depreciation and Depletion for 9 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion fell 2.02% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.1 million through Dec 2025, down 4.99% year-over-year, with the annual reading at $38.1 million for FY2025, 4.99% down from the prior year.
  • Depreciation and Depletion hit $9.7 million in Q4 2025 for Guardant Health, up from $9.0 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $10.3 million in Q3 2023 to a low of $4.5 million in Q1 2021.
  • Historically, Depreciation and Depletion has averaged $8.6 million across 5 years, with a median of $9.6 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: soared 82.0% in 2022 and later fell 10.89% in 2025.
  • Year by year, Depreciation and Depletion stood at $5.6 million in 2021, then surged by 69.64% to $9.5 million in 2022, then increased by 6.32% to $10.1 million in 2023, then fell by 1.98% to $9.9 million in 2024, then fell by 2.02% to $9.7 million in 2025.
  • Business Quant data shows Depreciation and Depletion for GH at $9.7 million in Q4 2025, $9.0 million in Q3 2025, and $9.6 million in Q2 2025.